Midwest Dermatology Conference
Virtual Experience Agenda

On-Demand Lectures available June 7 – August 10, 2021

On-Demand Lectures

Approved for 15 AAPA Category I CME Credit Hours

Biologics for Psoriasis: The “not so typical patient”

  • Recognize which patients are classified as fragile.
  • Understand the approach and work-up of a fragile patient.
  • Understand how to initiate biologic therapy in these patients.
  • Recognize which treatments are the safest in the patient population.

Michael Lewitt, MD

Urticaria Management

  • Understand how to differentiate between different causes and types of urticaria
  • Understand the proper work-up for the patient presenting with urticaria
  • Understand the management of urticaria and chronic urticaria.

Melissa Robinson, DO

Alternative and Additional Treatments for Hidradenitis Suppurativa

  • Recognize the psychosocial effects of Hidradenitis Suppurativa (HS) on patients and how to council this population.
  • Recognize co-morbidities associated with HS and how they can affect the overall disease severity.
  • Understand traditional treatments and alternative treatments of HS.

Jennifer Hsiao, MD

When to Think About the Zebras: Thinking Outside of the Box

  • Describe some of the “must not miss” zebras in dermatology
  • Outline some of the potential benefits of selected workup plans for several conditions
  • Identify some of the pitfalls and ramifications of missing a zebra in dermatology.

Peter Lio, MD

Integrative Approaches for Common Skin Concerns

  • Describe non-pharmacologic approaches to treating atopic dermatitis, acne, warts, and psoriasis
  • Outline some of the potential benefits of an integrative approach to skin diseases.
  • Identify some of the pitfalls, limitations, and knowledge gaps with integrative approaches.

Peter Lio, MD

Newest Anti-Infectives and Why We Need Them

  • Identify the newest agents to combat bacterial, fungal, and parasitic infections.
  • Recognize the latest approved and emerging vaccinations.
  • Understand the problems of resistance in the infectious disease world.

Ted Rosen, MD

Skin Lightening: Silent Dangerous Epidemic

  • Identify the historic and contemporary motivations behind skin lightening.
  • Recognize the various agents used in skin lightening products.
  • Understand the cutaneous and systemic threats skin lightening agents pose.

Ted Rosen, MD

Money Smart; You’re A PA, Now What?

  • Evaluate various approaches to student loans.
  • Distinguish the financial implications of consumer debt from student loan debt and explore how consumer debt types vary.
  • Specify how to determine the amount of money needed for a secure retirement.
  • Compare the various tax favored account types available for investing.
  • Recognize the benefits of early investing.
  • Determine how much money to invest monthly in order to achieve retirement goals.

Kristin Burton, MPAS, PA-C, CAQ-HM

Alopecia Areata: A New Understanding of Disease and the Role of JAK Inhibitors

  • Describe the comorbidities of alopecia areata and its association with polyautoimmune and inflammatory disease
  • Describe the pathogenesis of alopecia areata
  • Summarize the rationale for use of Janus kinase (JAK) inhibitors for alopecia areata
  • Outline a treatment algorithm for alopecia areata

Brett King, MD

The JAK-STAT Pathway and Novel Management of Atopic Dermatitis

  • Describe the comorbidities of atopic dermatitis
  • Describe the pathogenesis of atopic dermatitis
  • Summarize the rationale for use of Janus kinase (JAK) inhibitors for atopic dermatitis
  • Summarize treatment considerations for patients with atopic dermatitis

Brett King, MD

Surgical Pearls

  • To review the surgical approach for optimal outcomes in dermatologic procedures.
  • To discuss suturing techniques utilized in common repairs.
  • To provide preoperative and postoperative management pearls.

James Quertermous, MD

The Art of The Injectable Consultation

  • Participants will be able to complete a thorough initial cosmetic consultation.
  • Participants will be able to tailor patient education based on common cosmetic “personalities”.
  • Participants will be able to identify and deal with ‘red flags’ during assessment.

Nikki Love, BSN, RN, LE

AKs: New Paradigms and New and Evolving Therapies for 2021

  • Changing Paradigms: The classic Olsen clinical criteria for AKs and Rowert histologic classication for AKs do not correlate with each other or the development of Invasive squamous cell carcinoma (SCC).  The histologic finding of downward proliferation of atypical keratinocytes is more closely associated with the development of invasive SCC.
  • Optimizing efficacy and minimizing pain during PDT.  Efforts to enhance PDT efficacy while shortening the incubation period have made PDT more efficient but issues of pain during the treatment remain a significant drawback.  The evolution of “painless” PDT will be discussed, including “daylight mediated” PDT as well as the “simultaneous application/illumination” ALA PDT to minimize pain.
  • Newest Approved AK Field Therapy: Topical 1% Tirbanibulin ointment, an alpha tubulin inhibitor, has been recently approved for the treatment of AKs.  Efficacy, safety and tolerability data will be discussed as well as strategies aimed at optimizing treatment will be covered.
  • Do field therapies prevent Non-melanoma Skin Cancer (NMSC)?  Learn the outcomes of long term (36 month) studies using field therapies imiquimod, diclofenac and ingenol mebuate and the outcomes that led to the withdraw of ingenol mebuate from the US and EU market.

George Martin, MD

What’s New in the Acne Medicine Chest

  • To understand the research and technology behind the newest topical and oral medications for acne.
  • To apply the most updated research and technologies to the diagnosis and treatment of acne.
  • Improve skill in designing and prescribing acne treatment regimens.

Joshua Zeichner, MD

Procedures in Pediatrics

  • To discuss do’s and don’ts when doing/offering  office procedures
  • To give examples of scenarios  when to do a biopsy and when to refer and to clarify  the goals of a procedure.
  • To discuss tips and tricks on doing pediatric procedures
  • To point out possible common complications to anticipate post procedures in children and what to do about them.

Pearl Kwong, MD

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt